A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
- PMID: 16287075
- DOI: 10.1002/ijc.21611
A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening
Abstract
Cervical cancer remains a significant public health concern, both at a global and a European level. A number of new technologies such as diagnostic tests for human papillomavirus (HPV) have a potential to assist with the reduction of this disease. However, both the efficacy and the cost-effectiveness of these new technologies must be established in properly designed trials before they can be implemented within national public health programs. Our study reviews the randomized controlled trials that are currently being conducted in Europe to establish the performance of HPV testing as a primary cervical cancer screening test.
Similar articles
-
Human papillomavirus testing for primary cervical cancer screening.Expert Rev Mol Diagn. 2008 Sep;8(5):599-605. doi: 10.1586/14737159.8.5.599. Expert Rev Mol Diagn. 2008. PMID: 18785808 Review.
-
Human papillomavirus testing for primary cervical cancer screening.Curr Oncol Rep. 2008 Nov;10(6):533-7. doi: 10.1007/s11912-008-0081-0. Curr Oncol Rep. 2008. PMID: 18928670 Review.
-
Primary human papillomavirus testing in organized cervical screening.Curr Opin Obstet Gynecol. 2013 Feb;25(1):11-6. doi: 10.1097/GCO.0b013e32835c5d10. Curr Opin Obstet Gynecol. 2013. PMID: 23299089 Review.
-
Cervical cancer screening today. The role of HPV DNA testing.Adv Nurse Pract. 2006 Apr;14(4):24-9; quiz 30. Adv Nurse Pract. 2006. PMID: 16972469 Review. No abstract available.
-
Human papillomavirus infection and cervical cancer prevention in Japan and Korea.Vaccine. 2008 Aug 19;26 Suppl 12:M30-42. doi: 10.1016/j.vaccine.2008.05.006. Vaccine. 2008. PMID: 18945412
Cited by
-
Human papillomavirus testing versus repeat cytology for triage of minor cytological cervical lesions.Cochrane Database Syst Rev. 2013 Mar 28;2013(3):CD008054. doi: 10.1002/14651858.CD008054.pub2. Cochrane Database Syst Rev. 2013. PMID: 23543559 Free PMC article.
-
Inter-laboratory validation of PCR-based HPV detection in pathology specimens.Virchows Arch. 2007 Sep;451(3):701-16. doi: 10.1007/s00428-007-0437-0. Epub 2007 Jul 10. Virchows Arch. 2007. PMID: 17619898
-
Role of Dual-Staining p16/Ki-67 in the Management of Patients under 30 Years with ASC-US/L-SIL.Diagnostics (Basel). 2022 Feb 4;12(2):403. doi: 10.3390/diagnostics12020403. Diagnostics (Basel). 2022. PMID: 35204494 Free PMC article.
-
How to evaluate emerging technologies in cervical cancer screening?Int J Cancer. 2009 Dec 1;125(11):2489-96. doi: 10.1002/ijc.24774. Int J Cancer. 2009. PMID: 19626591 Free PMC article. Review.
-
Human papillomavirus testing in primary cervical screening and the cut-off level for hybrid capture 2 tests: systematic review.BMJ. 2011 May 23;342:d2757. doi: 10.1136/bmj.d2757. BMJ. 2011. PMID: 21606136 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical